Relay Therapeutics, Inc. announced that it has entered into a securities purchase agreement to issue 2,500,000 shares at a price of $12 per share for the gross proceeds of $30 million on January 8, 2024. The transaction will include participation from new investor, Nextech. The transaction is expected to close on January 10, 2024.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.58 USD | +1.08% | +2.34% | -40.33% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.33% | 864M | |
+33.27% | 50.85B | |
+0.98% | 42.82B | |
+49.00% | 42.03B | |
-4.22% | 29.55B | |
+10.98% | 26.11B | |
-21.63% | 19.13B | |
+8.37% | 13.05B | |
+27.18% | 12.16B | |
+23.37% | 12.08B |
- Stock Market
- Equities
- RLAY Stock
- News Relay Therapeutics, Inc.
- Relay Therapeutics, Inc. announced that it expects to receive $30 million in funding